Search

Author/Creator Efuni, Sergey

1. 287 Safety and antitumor activity of indoleamine 2, 3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors. (10th December 2020)

Authors:
Sahebjam, Solmaz; Muzaffar, Jameel; Yap, Timothy; Hong, David; Rixe, Olivier; Brown-Glaberman, Ursa; Varga, Andreea; Massard, Christophe; Baldini, Capucine; Efuni, Sergey; Kapelan, Barbara; Liu, Yi; Ogunmefun, Eniola; Tayama, Tomonori; Zhao, Henry; Healy, Denis; Latek, Robert; Nakashima, Daisuke;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 287 Safety and antitumor activity of indoleamine 2, 3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors. (9th November 2020)

Authors:
Sahebjam, Solmaz; Muzaffar, Jameel; Yap, Timothy; Hong, David; Rixe, Olivier; Brown-Glaberman, Ursa; Varga, Andreea; Massard, Christophe; Baldini, Capucine; Efuni, Sergey; Kapelan, Barbara; Liu, Yi; Ogunmefun, Eniola; Tayama, Tomonori; Zhao, Henry; Healy, Denis; Latek, Robert; Nakashima, Daisuke;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis. Issue 4 (17th December 2020)

Authors:
Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent
Journal:
Crohn's & colitis 360
Issue:
Volume 2:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis. Issue 3 (9th June 2020)

Authors:
Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent
Journal:
Crohn's & colitis 360
Issue:
Volume 2:Issue 3(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗